NCT06629129View on ClinicalTrials.gov

Effect of Latanoprost on Optic Nerve Perfusion

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions
Treatment Outcome
Interventions
DRUG

Latanoprost (0.005%)

MEAN OCULAR PERFUSION PRESSURE WAS MEASURED AND CORRELATED TO THE IOP AND OPTIC NERVE PERFUSION IN RESPONSE TO LATANOPROST TREATMENT

Trial Locations (1)

44511

Zagazig University, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT06629129 - Effect of Latanoprost on Optic Nerve Perfusion | Biotech Hunter | Biotech Hunter